- Independent in relation to the Company and its management: No
- Independent in relation to major shareholders: No
Dr Gregory Beatty (MD, PhD) is an Associate Professor at University of Pennsylvania Perelman School of Medicine, USA. Dr. Beatty’s clinical expertise is in early clinical trials for the treatment of gastrointestinal malignancies including pancreas, esophageal and colon carcinomas and he has led the first clinical study of CD40 immunotherapy for pancreatic cancer.